Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ad53b64eb74859acdc01278829b080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6573e77d3ac345e7315a57ba4ba756 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-00 |
filingDate |
2010-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-06-08^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8473949b5958c2062d67a38e521eafce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0025fc9be7d01daceac4a1a0e4302cee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ea0b1200b1fdad8a4a7b562275311b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029d4c7d3648e716ad3780891533f7ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28d512460510cb011a2f4df44637de6d |
publicationDate |
2015-06-08^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DK-2485756-T3 |
titleOfInvention |
GLP-2 for use in the treatment of muscle atrophy |
priorityDate |
2009-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |